Dr. Cameron Rokhsar, double board certified dermatologist and dermatologic surgeon, and world renowned laser surgeon, is proud to be among the first 5 physicians in the United States to offer the Accure laser technology, a treatment that is considered to be a game changer in the treatment of acne. First in Class, The Accure laser system with a wavelength of 1726, heats up the source of acne, the sebaceous gland, thereby decreasing the size of sebaceous glands, decreasing sebum production. Sebum’s breakdown products are considered proinflammatory causing red and cystic acne lesions. This targeted laser therapy of the sebaceous glands results in a significant decrease in inflammatory acne leading to long term remission in acne and potential cure.
Up until now, the only potential way to cure acne was through treatment with accutane (isotretinoin). Accutane has a 5-6 month course of pill that requires monthly blood work. Accutane provides a cure for acne in 60-70 percent of people. In some instances, people have to undergo accutane treatment for more than one cycle. Other treatments such as oral antibiotics (doxycycline, minocycline), topical antibiotics (clindamycin, erythromycin), topical anti-inflammatories (aczone), topical retinoids (retin-a, differin, tazorac) would only give temporary relief for acne as long as in use by the patient. Oftentimes, patients build tolerance to treatments and have to be switched between these modalities.
Finally, we have a long term solution for treatment of acne in the form of a revolutionary laser, named Accure. Dr. Cameron Rokhsar has been a pioneer in the field of lasers, and has introduced many revolutionary lasers such as Fraxel, Ulthera, fractional CO2, and Miradry to the world. Dr. Rokhsar is pleased to be among the first in New York and the world to introduce this revolutionary laser procedure for long term improvement of acne to all acne patients in Manhattan, Queens, Brooklyn, Staten Island, Bronx, Nassau county, Suffolk county, Westchester county and New Jersey. Dr. Rokhsar can treat all types of acne including mild, moderate and severe acne with the Accure laser.
Acne vulgaris is the most common skin disease treated by Dermatologists and clinicians nationwide. Acne Vulgaris, the most common form of acne on the face and body, is largely caused by overproduction of sebum by sebaceous glands, which often clogs pores. When sebum, bacteria, and dead skin cells accumulate inside pores, they form whiteheads, blackheads, or pimples. While there is no known cure for acne, it can be managed with prescription medications. However, even with the strongest prescriptions and medical-grade skin care products, some patients still suffer from stubborn acne breakouts. Many acne patients may find themselves unable to tolerate the side effects of prescription drugs. Dealing with acne can be frustrating for individuals of any age and, as a result, many people struggle with feeling confident in their skin.
Dr. Rokhsar is proud to be offering the revolutionary laser procedure, Accure, in the treatment of acne. The Accure laser technology precisely targets sebaceous glands in the skin to neutralize them to decrease sebum production on a long term basis. The laser keeps the surface of the skin intact making it safe for all skin types and skin colors including asian skin, black skin, hispanic skin, and indian skin with minimal risk of scarring.
Development of the Accure laser began in 2013. The Accure laser system has been undergoing extensive testing and development for almost a decade. It was first introduced for clinical trials in 2017 and FDA cleared for treatment of mild to severe inflammatory acne vulgaris on the face and body in 2022. The laser uses a 1726-nm beam to selectively target sebaceous glands to shrink them while keeping the surface of the skin intact. It is FDA approved for the treatment of mild, moderate and severe acne in teens and adults.
The Accure Laser system is safe for the treatment of mild to severe acne vulgaris in teens and adults. The laser targets sebaceous glands below the skin and keeps the surface of the skin intact, which makes it safe for use in individuals of all skin types with minimal risk of scarring.
The current protocol involves undergoing treatment with the laser four times at 2-4 week treatment intervals. Pain control is achieved through numbing cream. Very sensitive patients can choose to take Pronox gas (laughing gas) or having numbing injections administered.
Face is the most common treatment area with the Accure laser. Other body areas such as the back, shoulders, and the chest can also be safely treated.
Both the Aviclear laser system and the Accure laser system are FDA approved for acne. They are currently the only two laser systems FDA approved for laser treatment of mild to severe acne promising long lasting results. They both have the wavelength of 1726 nm, which is the appropriate wavelength to target sebaceous glands in the skin. The Accure laser system has been under research and development for almost ten years, where as research on the AviClear laser system has been considerably shorter. In addition only the Accure system has precise temperature monitoring of the surface of the skin to ensure utmost safety and also proper heating of the right layer of skin where the sebaceous glands reside leading to increased effectiveness. Most expert laser dermatologists believe that the Accure laser system is not only safer but also works better for the treatment of acne. There have been many cases of non responders reported with the AviClear laser system for the treatment of acne.
Upper East Side Manhattan Office
121 East 60th Street, Suite 8AB New York, NY 10022
(212) 285-1110
Long Island Office
901 Stewart Ave, Suite 240, Garden City, NY 11530
(516) 512-7616
Dr. Cameron Rokhsar, MD, FAAD, FAACS, is the founder and medical director of the New York Cosmetic, Skin, & Laser Surgery Center. Dr. Rokhsar is a graduate of Harvard College and NYU School of Medicine. Dr. Rokhsar is double board certified in dermatology and micrographic dermatologic surgery, being one of the few select dermatologists in the country who is also fellowship trained in laser surgery. A researcher and innovator, Dr. Rokhsar is the creator of the non-surgical nose job and has been instrumental in the research and development of laser systems such as the Fraxel, CO2, Mirady, Vbeam, Themitight, and Ulthera devices. An Associate Professor of Dermatology at Mount Sinai Hospital in NYC, Dr. Rokhsar actively teaches the cosmetic dermatology clinic to the resident at Mount Sinai. An expert injector of fillers, and a trainer for many companies, patients fly in from around the world to see Dr. Rokhsar in his Garden City and Manhattan offices in New York.
Dr. Rokhsar was chosen by
magazine as a top dermatologist in its Best Doctors 2017, 2018, 2019, 2020, 2021, 2022 and 2023 issues.
